Medical management of extremely low-birth-weight infants in the first week of life: A survey of practices in the United States

American Journal of Perinatology

Volumn 26, Issue 6, 2009, Pages 407-418

  Kiefer, Autumn S ^a   Wickremasinghe, Andrea C ^a   Johnson, Jonathan N ^a   Hartman, Tyler K ^b   Hintz, Susan R ^c   Carey, William A ^a   Colby, Christopher E ^a  

^a MAYO CLINIC   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

Corticosteroids; Extremely low birth weight; Neonatal resuscitation; Practice variation; Survey

Indexed keywords

ALPHA TOCOPHEROL; AMPICILLIN; CEFOTAXIME; DEXAMETHASONE; FLUCONAZOLE; GENTAMICIN; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; NITRIC OXIDE; RETINOL; VANCOMYCIN;

ARTICLE; BRAIN HEMORRHAGE; BREAST MILK; DRUG EFFICACY; DRUG SAFETY; EXTREMELY LOW BIRTH WEIGHT; HUMAN; HYPOTENSION; MEDICAL PRACTICE; NEWBORN; NEWBORN CARE; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; PARENTERAL NUTRITION; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY CARE; RESPIRATORY FAILURE; RESUSCITATION; TOTAL PARENTERAL NUTRITION; UNITED STATES;

ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CEREBRAL HEMORRHAGE; DUCTUS ARTERIOSUS, PATENT; HEALTH CARE SURVEYS; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFECTION; NEONATOLOGY; PARENTERAL NUTRITION, TOTAL; PHYSICIAN'S PRACTICE PATTERNS; RESPIRATORY THERAPY; UNITED STATES;

EID: 67649364642     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0029-1214235     Document Type: Article

References (64)

1. Resuscitation of Babies Born Preterm. In: Kattwinkel J, ed. Neonatal Resuscitation. 5th ed. American Academy of Pediatrics and the American Heart Association; 2006:8-1-8-16
2. Saugstad OD, Ramji S, Vento M. Resuscitation of depressed newborn infants with ambient air or pure oxygen: a meta-analysis. Biol Neonate 2005;87:27-34 (Pubitemid 40091375)
3. Tan A, Schulze A, O'Donnell CP, Davis PG. Air versus oxygen for resuscitation of infants at birth. Cochrane Database Syst Rev 2005;(2):CD002273
4. Wang CL, Anderson C, Leone TA, Rich W, Govindaswami B, Finer NN. Resuscitation of preterm neonates using room air or 100% oxygen. Pediatrics 2008;121:1083-1089
5. Courtney SE, Durand DJ, Asselin JM, Hudak ML, Aschner JL, Shoemaker CT. High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants. N Engl J Med 2002;347:643-652 (Pubitemid 34970867)
6. Keszler M, Modanlou HD, Brudno DS, et al. Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome. Pediatrics 1997;100:593-599 (Pubitemid 27425981)
7. Fowlie PW, Davis PG. Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002;(3):CD000174
8. Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001;344:1966-1972 (Pubitemid 32568150)
9. Noori S, Friedlich P, Wong P, Ebrahimi M, Siassi B, Seri I. Hemodynamic changes after low-dosage hydrocortisone administration in vasopressor-treated preterm and term neonates. Pediatrics 2006;118:1456-1466 (Pubitemid 46393791)
10. Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. N Engl J Med 2001;344:95-100 (Pubitemid 32052498)
11. LeFlore JL, Salhab WA, Broyles RS, Engle WD. Association of antenatal and postnatal dexamethasone exposure with outcomes in extremely low birth weight neonates. Pediatrics 2002;110:275-279 (Pubitemid 34833010)
12. Craft AP, Finer NN, Barrington KJ. Vancomycin for prophylaxis against sepsis in preterm neonates. Cochrane Database Syst Rev 2000;(2):CD001971
13. Clerihew L, Austin N, McGuire W. Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev 2007;(4):CD003850 (Pubitemid 351805355)
14. Tyson JE, Kennedy KA. Trophic feedings for parenterally fed infants. Cochrane Database Syst Rev 2005;(3):CD000504
15. Berseth CL, Bisquera JA, Paje VU. Prolonging small feeding volumes early in life decreases the incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2003;111:529-534 (Pubitemid 36330708)
16. Saugstad OD, Ramji S, Irani SF, et al. Resuscitation of newborn infants with 21% or 100% oxygen: follow-up at 18 to 24 months. Pediatrics 2003;112:296-300 (Pubitemid 36951389)
17. Engle WA and the Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008;121:419-432
18. Narendran V, Donovan EF, Hoath SB, Akinbi HT, Steichen JJ, Jobe AH. Early bubble CPAP and outcomes in ELBW preterm infants. J Perinatol 2003;23:195-199 (Pubitemid 36656518)
19. Aly H, Milner JD, Patel K, El-Mohandes AAE. Does the experience with the use of nasal continuous positive airway pressure improve over time in extremely low birth weight infants? Pediatrics 2004;114:697-702
20. Morley CJ, Davis PG, Doyle LW, et al. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008;358:700-708 (Pubitemid 351240749)
21. Henderson-Smart DJ, Cools F, Bhuta T, Offringa M. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants. Cochrane Database Syst Rev 2007;(3):CD000104 (Pubitemid 351805496)
22. Truffert P, Paris-Llado J, Escande B, et al. Neuromotor outcome at 2 years of very preterm infants who were treated with high-frequency oscillatory ventilation or conventional ventilation for neonatal respiratory distress syndrome. Pediatrics 2007;119:e860-e865 (Pubitemid 46556649)
23. Vanderveen DK, Mansfield TA, Eichenwald EC. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J AAPOS 2006;10:445-448 (Pubitemid 44633728)
24. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003;349:959-967 (Pubitemid 37064769)
25. Barrington KJ, Finer NN. Inhaled nitric oxide for respiratory failure in preterm infants. Cochrane Database Syst Rev 2007;(3):CD000509 (Pubitemid 351805525)
26. Van Meurs KP, Wright LL, Ehrenkranz RA, et al. Inhaled nitric oxide for premature infants with severe respiratory failure. N Engl J Med 2005;353:13-22 (Pubitemid 41007803)
27. Van Overmeire B, Allegaert K, Casaer A, et al. Prophylactic ibuprofen in premature infants; a multicentre, randomized, double blind, placebo-controlled trial. Lancet 2004;364:1945-1949 (Pubitemid 39574597)
28. Pezzati M, Vangi V, Biagotti R, Bertini G, Cianciulli D, Rubaltelli F. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999;135:733-738 (Pubitemid 30180423)
29. Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2003;(2):CD003481
30. Gournay V, Savagner C, Thiriez G, Kuster A, Roze J-C. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002;359:1486-1488 (Pubitemid 34457769)
31. Bellini C, Campone F, Serra G. Pulmonary hypertension following L-lysine ibuprofen therapy in a preterm infant with patent ductus arteriosus. CMAJ 2006;174:1843-1844 (Pubitemid 43974089)
32. Huysman MW, Hokken-Koelega AC, DeRidder MA, Sauer PJ. Adrenal function in sick very preterm infants. Pediatr Res 2000;48:629-633 (Pubitemid 30808971)
33. Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institutes of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics 2001;107:E1
34. Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2003;(1):CD001146
35. The Vermont Oxford Network Steroid Study Group. Early postnatal dexamethasone therapy for prevention of chronic lung disease. Pediatrics 2001;108:741-748
36. Karemaker R, Kavelaars A, ter Wolbeek M, et al. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamus-pituitary-adrenal axis and immune system activity at school age. Pediatrics 2008;121:e870-e878
37. Watterberg KL, Gerdes JS, Cole CH, et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004;114:1649-1657 (Pubitemid 41754933)
38. Watterberg KL, Shaffer ML, Mishefske MJ, et al. Growth and neurodevelopmental outcomes after early low-dose hydrocortisone treatment in extremely low birth weight infants. Pediatrics 2007;120:40-48 (Pubitemid 47036239)
39. American Academy of Pediatrics Committee on Fetus and Newborn, Canadian Paediatric Society Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002;109:330-338
40. Doyle LW, Davis PG, Morley CJ, McPhee A, Carlin JB. the DART study investigators. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized controlled trial. Pediatrics 2006;117:75-83
41. Attridge JT, Clark R, Walker MW, Gordon PV. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2006;26:93-99
42. Thureen PJ, Hay WW Jr. Intravenous nutrition and postnatal growth of the micropremie. Clin Perinatol 2000;27:197-219 (Pubitemid 30109072)
43. Simmer K, Rao SC. Early introduction of lipids to parenterally-fed preterm infants. Cochrane Database Syst Rev 2005;(2):CD005256
44. Poindexter BB, Langer JC, Dusick AM, Ehrenkranz RA. Early provision of parenteral amino acids in extremely low birth weight infants: relation to growth and neurodevelopmental outcome. J Pediatr 2006;148:300-305
45. Clark RH, Chace DH, Spitzer AR; for the Pediatrix Amino Acid Study Group. Effects of two different doses of amino acid supplementation on growth and blood amino acid levels in premature neonates admitted to the neonatal intensive care unit: a randomized, controlled trial. Pediatrics 2007;120:1286-1296
46. Guillet R, Stoll BJ, Cotton CM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006;117:e137-e142 (Pubitemid 46071566)
47. American Academy of Pediatrics. Section on Breastfeeding. Policy Statement: breastfeeding and the use of human milk. Pediatrics 2005;115:496-506
48. Schanler RJ, Lau C, Hurst NM, O'Brian Smith E. Randomized trial of donor human milk versus preterm formula as substitutes for mothers' own milk in the feeding of extremely premature infants. Pediatrics 2005;116:400-406 (Pubitemid 44161466)
49. Davey AM, Wagner CL, Cox C, Kendig JW. Feeding premature infants while low umbilical artery catheters are in place: a prospective, randomized trial. J Pediatr 1994;124:795-799 (Pubitemid 24161475)
50. Darlow BA, Graham PJ. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev 2007;(4):CD000501 (Pubitemid 351805410)
51. Tyson JE, Wright LL, Oh W. Vitamin A supplementation for extremely-low-birth-weight infants. N Engl J Med 1999;340:1962-1968 (Pubitemid 29288272)
52. Ambalavanan N, Kennedy K, Tyson J, Carlo WA. Survey of vitamin A supplementation for extremely-low-birth-weight infants: is clinical practice consistent with the evidence? J Pediatr 2004;145:304-307
53. Brion LP, Bell EF, Raghuveer TS. Vitamin E supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2003;(3):CD003665
54. Hodgman JE, Barton L, Pavlova Z, Fassett MJ. Infection as a cause of death in the extremely-low-birth-weight infant. J Matern Fetal Neonatal Med 2003;14:313-317 (Pubitemid 37485383)
55. Stoll BJ, Gordon T, Korones SB, et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 1996;129:72-80 (Pubitemid 26277249)
56. American Academy of Pediatrics, Committee on Infectious Disease and Committee on Fetus and Newborn. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. Pediatrics 1997;99:489-496
57. World Health Organization Department of Child and Adolescent Health and Development. Explore Simplified Antimicrobial Regimens for the Treatment of Neonatal Sepsis. Meeting report, September 30 to October 1, 2002; Geneva, Switzerland: WHO; 2003; (WHO/FCH/CAH/04.1)
58. Modi N, Damjanovic V, Cooke RW. Outbreak of cephalosporin- resistant Enterobacter cloacae infection in a neonatal intensive care unit. Arch Dis Child 1987;62:148-151 (Pubitemid 17004195)
59. Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006;117:67-74 (Pubitemid 46050521)
60. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285-291 (Pubitemid 34833012)
61. Maayan-Metzger A, Linder N, Marom D, Vishne T, Ashkenazi S, Sirota L. Clinical and laboratory impact of coagulase-negative staphylococci bacteremia in preterm infants. Acta Paediatr 2000;89:690-693 (Pubitemid 30624914)
62. Gray JE, Richardson DK, McCormick MC, Goldmann DA. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics 1995;95:225-230
63. Center for Disease Control and Prevention. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep 2002;51(RR-10):1-29
64. Benjamin DK Jr, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006;117:84-92 (Pubitemid 46050523)